Safety and tolerability in oncology trials: Cardiac imaging, ECG and the role for patient-reported outcomes webinar replay
As clinical research in the oncology therapeutic area becomes increasingly complex, effectively capturing high-quality data across multiple endpoints becomes even more critical to a drug’s success. Many oncologic agents have cardiac toxicities, including depression of left ventricular function, QTc prolongation and elevation of blood pressure.
Watch this webinar replay to learn about the intersection of oncology drug development and cardiac safety, and how this new area is changing the landscape for early-phase clinical trials.
Subscribe to our newsletter
Stay up to date with the latest insights and best practices by subscribing to our newsletter. You’ll receive notifications whenever we publish new webinar replays, blog posts and other downloadable resources.